Acurx Pharmaceuticals growth metrics data for the quarter ended Jun 2026. These growth metrics cover 5 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|
| Growth Ratios | |||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | 18,709.00 | 10,926.00 | |||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 9,172.00 | 3,285.00 | 3,405.00 | 2,846.00 | 1,390.00 |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 52,327.00 | 24,508.00 | |||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 30,032.00 | 9,530.00 | 7,224.00 | 5,541.00 | 2,213.00 |